PT-141 10mg

Description

PT-141 10mg is listed by Purity Collective as a lyophilized research peptide for qualified laboratory procurement. This page is written to help a purchaser confirm the catalog identity, vial quantity, current batch documents and research-use boundary before ordering.

PT-141 10mg catalog facts

• Product: PT-141 10mg
• Format: Lyophilized vial
• Listed quantity: 10mg
• SKU: PC-PT-141-10MG
• Current certificate batch: PCCL-2061592-P

Available documentation

The current product attachments include a UPLC/MS report and a separate endotoxin report. Review both files together because identity, quantity, purity and endotoxin information are split across separate PDFs. For PT-141 identity context and product-record boundaries, read the PT-141 research records and documentation review guide.

• UPLC/MS report for batch PCCL-2061592-P
• Endotoxin report for related batch PCCL-2061592-E
• How to read a peptide COA

UPLC/MS report details

The UPLC/MS report lists PT-141 with a 10mg specification, a 9.79mg quantity result and 99.25% purity. These are sample-specific analytical results for the tested lot; they should not be rewritten as a broad product-wide or future-lot guarantee.

Endotoxin report details

The endotoxin PDF lists related batch PCCL-2061592-E and reports 0.075 EU/mL. The UPLC/MS and endotoxin reports show analysis conducted on May 4, 2026 and a received date of May 9, 2026, so the chronology should be read exactly as printed. The endotoxin report does not print a separate acceptance specification.

Documentation scope

The current documents support a cautious review of the listed research peptide, its vial quantity and the attached batch records. They do not convert the product into a treatment, wellness, performance or human-use product, and they should not be used to imply clinical suitability.

PT-141 10mg FAQs

What is listed on this page?

This page lists PT-141 10mg from Purity Collective as a lyophilized vial for qualified laboratory research, with SKU PC-PT-141-10MG and current documentation tied to batch PCCL-2061592-P.

Which analytical documents are available?

The listing includes a UPLC/MS report for batch PCCL-2061592-P and a separate endotoxin report for related batch PCCL-2061592-E. Both PDFs should be reviewed together before procurement.

What quantity result is shown on the UPLC/MS report?

The UPLC/MS report lists a 10mg specification and a 9.79mg quantity result for the tested PT-141 sample.

Does 99.25% describe every future vial?

No. The 99.25% value is the purity result printed for the tested sample in the current UPLC/MS report. Public copy should keep that result tied to the listed batch documentation.

Is PT-141 10mg intended for human use?

No. This listing is for qualified laboratory research use only. It is not offered for human or veterinary use, and no protocol, handling or use-protocol guidance is provided.

Research-use notice

Review the product label, batch documentation and institutional requirements before procurement. If a required certificate, specification or document field is not visible, treat that information as unverified until the current product documentation is supplied.